Home › NDC Lookup › RxCUI directory › RxCUI 861646

Pitavastatin calcium 1 MG Oral Tablet [Livalo] — RxCUI 861646

RxNorm drug concept · Semantic branded drug
RxCUI 861646 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI861646
Official namePitavastatin calcium 1 MG Oral Tablet [Livalo]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asLivalo 1 MG Oral Tablet; Livalo 1 MG (as pitavastatin calcium 1.045 MG) Oral Tablet
FDA products mapped3
Package NDCs mapped3
Reported Medicaid activity (SDUD)1,313 prescriptions · 6 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Pitavastatin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Pitavastatin lowers LDL — that's the 'bad' cholesterol that can build up in your arteries. It works by blocking the main enzyme your liver uses to make cholesterol, so the liver en...
  • What exactly is pitavastatin supposed to do for me?
  • You can take pitavastatin with or without food — it won't cause stomach issues either way. Morning or evening both work, though evening dosing may give a slightly better LDL reduct...
  • Does it matter what time of day I take it, or whether I eat first?
📖 Read our full Pitavastatin guide →

🕸️ Concept Web — How Pitavastatin calcium 1 MG Oral Tablet [Livalo] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Pitavastatin calcium 1 MG Oral Tablet [Livalo] RxCUI 861646

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Pitavastatin 861634
    • Pitavastatin calcium 861640
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Livalo 861612
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Pitavastatin Oral Tablet 861642
    • Pitavastatin calcium Oral Tablet 2646105
    • Pitavastatin Oral Product 1163274
    • Pitavastatin Pill 1164454
    • Pitavastatin calcium Oral Product 2661588
    • Pitavastatin calcium Pill 2661907
    • Pitavastatin Oral Tablet [Livalo] 861645
    • Pitavastatin calcium Oral Tablet [Livalo] 2658509
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Pitavastatin calcium 1 MG Oral Tablet SCD · 861643
  • Pitavastatin calcium 1 MG SCDC · 2001322
  • Pitavastatin Oral Tablet SCDF · 861642
  • Pitavastatin calcium Oral Tablet SCDFP · 2646105
  • Pitavastatin Oral Product SCDG · 1163274
  • Pitavastatin Pill SCDG · 1164454
  • Pitavastatin calcium Oral Product SCDGP · 2661588
  • Pitavastatin calcium Pill SCDGP · 2661907

Brand-Name Concepts

  • Pitavastatin calcium 1 MG [Livalo] SBDC · 2001324
  • Pitavastatin Oral Tablet [Livalo] SBDF · 861645
  • Pitavastatin calcium Oral Tablet [Livalo] SBDFP · 2658509
  • Livalo Oral Product SBDG · 1179132
  • Livalo Pill SBDG · 1179133
  • Livalo BN · 861612

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 861646 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
66869-0104-90 90 TABLET, FILM COATED in 1 BOTTLE, DISPENSING (66869-104-90... Livalo Kowa Pharmaceuticals America, Inc. 2019-05-16
66869-0204-90 90 TABLET, FILM COATED in 1 BOTTLE, DISPENSING (66869-204-90... Livalo Kowa Pharmaceuticals America, Inc. 2019-05-16
66869-0404-90 90 TABLET, FILM COATED in 1 BOTTLE, DISPENSING (66869-404-90... Livalo Kowa Pharmaceuticals America, Inc. 2019-05-16
Observed labelers: Kowa Pharmaceuticals America, Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.